Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 10/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1959135 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL6813217 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL1855223 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL1538975 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL7179959 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL8735592 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL150721 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL11652942 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Hydrochloric Acid SCHEMBL6563761 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1MEN1 | |
| Hexane SCHEMBL11105002 | 1.00 | TSHR (0.57) | TSHRTHRBDNM1ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1976821-B1 | DIRECT ALKYLATION OF N-ALKYL-N'-PHENYL-P-PHENYLENEDIAMINE | CHEMTURA CORP (US) | 2011-05-25 | — | — | EP | claimed |
| EP-1976821-A1 | DIRECT ALKYLATION OF N-ALKYL-N'-PHENYL-P-PHENYLENEDIAMINE | CHEMTURA CORPORATION (US) | 2008-10-08 | — | — | EP | claimed |
| US-7361788-B2 | Direct alkylation of N-alkyl-N′-phenyl-p-phenylenediamine | CHEMTURA CORPORATION (US) | 2008-04-22 | — | — | US | claimed |
| WO-2007087195-A1 | DIRECT ALKYLATION OF N-ALKYL-N'-PHENYL-P-PHENYLENEDIAMINE | CHEMTURA CORPORATION (US) | 2007-08-02 | — | — | WO | claimed |
| US-20070173668-A1 | Direct alkylation of N-alkyl-N'-phenyl-p-phenylenediamine | LANXESS SOLUTIONS US INC. | 2007-07-26 | — | — | US | claimed |
| EP-1976821-B1 | DIRECT ALKYLATION OF N-ALKYL-N'-PHENYL-P-PHENYLENEDIAMINE | CHEMTURA CORP (US) | 2011-05-25 | — | — | EP | disclosed |
| EP-1976821-A1 | DIRECT ALKYLATION OF N-ALKYL-N'-PHENYL-P-PHENYLENEDIAMINE | CHEMTURA CORPORATION (US) | 2008-10-08 | — | — | EP | disclosed |
| US-7361788-B2 | Direct alkylation of N-alkyl-N′-phenyl-p-phenylenediamine | CHEMTURA CORPORATION (US) | 2008-04-22 | — | — | US | disclosed |
| WO-2007087195-A1 | DIRECT ALKYLATION OF N-ALKYL-N'-PHENYL-P-PHENYLENEDIAMINE | CHEMTURA CORPORATION (US) | 2007-08-02 | — | — | WO | disclosed |
| US-20070173668-A1 | Direct alkylation of N-alkyl-N'-phenyl-p-phenylenediamine | LANXESS SOLUTIONS US INC. | 2007-07-26 | — | — | US | disclosed |
| EP-0968992-A1 | Process for producing lanthanide series metal corboxylates and their use for the polymerization of diene monomers | Chi Mei Corporation (TW) | 2000-01-05 | — | — | EP | disclosed |
| EP-0652240-B1 | Process for polybutadiene production using catalyst with high activity | BAYER INC (CA) | 1998-01-28 | — | — | EP | disclosed |
| US-4254294-A | FOR POLYMERIZATION OF OLEFINIC HYDROCARBONS | INSTITUT FRANCAIS DU PETROLE (FR) | 1981-03-03 | — | — | US | disclosed |
| US-4237254-A | USING A SOLID CATALYST OF ORGANOALUMINUM COMPONENT, MAGNESIUM HYDROXYHALIDE, A CARBOXYLIC ESTER AND A TITANIUM HALIDE | MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) | 1980-12-02 | — | — | US | disclosed |
| US-4107418-A | OF AN ACRYLIC MONOMER AND ANOTHER UNSATURATED MONOMER; CATALYST COMPRISING AN ORGANOALUMINUM HALIDE AND ORGANIC PEROXIDE | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1978-08-15 | — | — | US | disclosed |
| US-4092371-A | ALKYLATION CATALYSTS | INSTITUT FRANCAIS DU PETROLE (FR) | 1978-05-30 | — | — | US | disclosed |
| US-4062805-A | Process for manufacturing a catalyst comprising aluminum oxide and boron oxide, the resulting catalyst and the use thereof in alkylation reactions | INSTITUT FRANCAIS DU PETROLE (FR) | 1977-12-13 | — | — | US | disclosed |
| US-4054612-A | HOMO- OR COPOLYMERIZATION OF BUTADIENE, CATALYTIC | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-10-18 | — | — | US | disclosed |
| US-4052473-A | OF ISOPRENE, NICKEL-ALKYLAMUMIN HALIDE CONTAINING CATALYST | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-10-04 | — | — | US | disclosed |
| US-3980727-A | TRANSALKYLATING TOLUENE WITH POLY-METHYL BENZENE HYDROCARBONS IN A CATALYST | INSTITUT FRANCAIS DU PETROLE, DES CARBURANTS ET LUBRIFIANTS ET ENTREPRISE DE RECHERCHES ET D'ACTIVITIES PETROLIERES ELF (FR) | 1976-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173668-A1 | Direct alkylation of N-alkyl-N'-phenyl-p-phenylenediamine | PNMT, AAAS, PNN | TSHR 4484/4885THRB 4663/4885DNM1 1649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.